Aggressive NK cell leukaemia (Q39122): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Leucemia rara, altamente agressiva, associada ao vírus Epstein-Barr, também conhecida como leucemia/linfoma agressivo de células NK; pode representar a contraparte leucêmica dos linfomas de células NK/T extranodais do tipo nasal. Afeta primariamente adolescentes e adultos jovens. É caracterizada pela proliferação sistêmica de células NK em sangue periférico, medula óssea, fígado e baço. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A rare, highly aggressive, Epstein-Barr virus-associated leukaemia, also known as aggressive NK-cell leukaemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterised by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/153957345 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:2A90.3 | |||||||||||||||
| Property / CURIE: CID11:2A90.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-2A90.3 | |||||||||||||||
| Property / Canary Token: dki-india-2A90.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: C86 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 04:26, 13 August 2026
A rare, highly aggressive, Epstein-Barr virus-associated leukaemia, also known as aggressive NK-cell leukaemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterised by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A90.3 |
||
| English | Aggressive NK cell leukaemia |
A rare, highly aggressive, Epstein-Barr virus-associated leukaemia, also known as aggressive NK-cell leukaemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterised by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen. |
Statements
CID11:2A90.3
0 references
dki-india-2A90.3
0 references
Concluído
0 references
13 August 2026
0 references
